The vaccine development process and coordination between health organizations have improved since a devastating 2014-2016 ...

ACT-CHIK, a project led by Institut Pasteur, will advance chikungunya vaccine trials across four African countries.

INCHEON, South Korea, June 9, 2026 /PRNewswire/ -- SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that, ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. While the media's attention has focused on unproven links between ...

Advanced analytical services support partners from product characterization and assay development to GMP readiness and clinical manufacturing ...

IAVI, Moderna and the University of Oxford are all working on new vaccines.

Vaccine development is traditionally driven by financial return opportunities for investors, disease outbreaks, and a specific focus on emerging diseases. However, a new systematic, transparent, and ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...

As the Ebola epidemic raging in the Democratic Republic of the Congo shows no signs of abating, researchers around the world ...

Vaccine development for aquaculture species encompasses a diverse array of approaches designed to prevent bacterial, viral and parasitic diseases in farmed fish. Conventional strategies include ...

SK bioscience licenses vaccine technology from the U.S. Centers for Disease Control and PreventionSK bioscience is jointly ...